Sermorelin acetate injection
The platform publishes a sermorelin pathway with telehealth consultation and laboratory review; eligibility and formulation require confirmation.
Provider source ↗
Charlotte, NC · Telehealth available
Provider overview
Premier Hormone Health & Wellness publishes a Charlotte contact office, a named clinical leadership team, virtual consultation and laboratory pathways, and service across all 50 states. Current treatment pages advertise sermorelin, thymosin alpha-1, PT-141, and hexarelin. These are provider-published offerings; the directory does not establish approval status, pharmacy source, formulation, legal availability, safety, effectiveness, or individual eligibility.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
The platform publishes a sermorelin pathway with telehealth consultation and laboratory review; eligibility and formulation require confirmation.
Provider source ↗A current treatment page advertises thymosin alpha-1 through virtual consultation without an editorial claim about benefit.
Provider source ↗The provider publishes a dedicated hexarelin page; inclusion here does not establish regulatory status or availability.
Provider source ↗PT-141 is published as a telehealth sexual-health option after provider evaluation.
Provider source ↗The peptide pathway describes virtual consultation, laboratory testing, treatment planning, and follow-up.
Provider source ↗The official site lists clinician-guided hormone care for men and women among its principal virtual programs.
Provider source ↗Weight-management evaluation is published as a telehealth service subject to clinician assessment.
Provider source ↗The platform publishes sexual-health and performance-oriented programs alongside hormone and peptide care.
Provider source ↗Treatment pages describe continuing clinician follow-up after laboratory review and initial consultation.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity contact care model and service scope · Checked Aug 3, 2026
Supports: leadership and clinical team · Checked Aug 3, 2026
Supports: sermorelin program location and care path · Checked Aug 3, 2026
Supports: thymosin alpha1 and all state coverage · Checked Aug 3, 2026
Supports: pt141 program · Checked Aug 3, 2026
Supports: hexarelin program · Checked Aug 3, 2026